Review



cpass svnt “wild type” kit  (GenScript corporation)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    GenScript corporation cpass svnt “wild type” kit
    Cpass Svnt “Wild Type” Kit, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cpass+svnt/cpass+svnt+kit/pm40288233-74-9-9
    Average 90 stars, based on 1 article reviews
    cpass svnt “wild type” kit - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    Binding Assay:

    Article Title: Advances in Surrogate Neutralization Tests for High-Throughput Screening and the Point-of-Care
    Article Snippet: .. Ahn et al. immobilized ACE2 via His 6 -tag for improved binding of RBD ( Figure b) compared to the commercial cPass sVNT from GenScript ( Figure a). ..

    Article Title: Advances in Surrogate Neutralization Tests for High-Throughput Screening and the Point-of-Care.
    Article Snippet: .. Ahn et al. immobilized ACE2 via His6-tag for improved binding of RBD (Figure 3b) compared to the commercial cPass sVNT from GenScript (Figure 3a).62 They biotinylated RBD using sulfo-NHS-biotin, which is a simple but random strategy because not only the N-terminus but also lysine residues can be biotinylated. ..

    Infection:

    Article Title: Evaluation of commercially available fully automated and ELISA-based assays for detecting anti-SARS-CoV-2 neutralizing antibodies
    Article Snippet: .. Further, GenScript cPass sVNT exhibited the best linear correlation with pVNT in samples collected from both infected and vaccinated individuals. .. These results are consistent with previous studies assessing the performance of GenScript sVNT compared to MNA and pVNT, demonstrating high specificity and even more sensitivity , , , .

    Article Title: Evaluation of commercially available fully automated and ELISA-based assays for detecting anti-SARS-CoV-2 neutralizing antibodies.
    Article Snippet: .. Further, GenScript cPass sVNT exhibited the best linear correlation with pVNT in samples collected from both infected and vaccinated individuals. .. These results are consistent with previous studies assessing the performance of GenScript sVNT compared to MNA and pVNT, demonstrating high specificity and even more sensitivity7,30,33,34.

    Neutralization:

    Article Title: Longitudinal neutralizing antibody responses after SARS-CoV-2 infection: A convalescent cohort study in Taiwan.
    Article Snippet: .. This optimized threshold was utilized in our determination of antibody protection as 1:80.33,34 Based on one study that they determined NAb cutoff titer (titerS80) as suitable for comparing immunoassays and the other study estimated the 50% protective neutralization level as 54 IU/ml (95% CI 30e96 IU/ml), we set the cutoff titer as titerS80 and S 45.97 IU/m for the virus-live neutralizing assay.35,36 To assure our lab results performance, a subset of samples was tested by using other platforms of GenScript cPass sVNT, indicating that two platforms robustly correlated with specific titers of neutralizing antibodies for samples from acute phase. ..

    Virus:

    Article Title: Longitudinal neutralizing antibody responses after SARS-CoV-2 infection: A convalescent cohort study in Taiwan.
    Article Snippet: .. This optimized threshold was utilized in our determination of antibody protection as 1:80.33,34 Based on one study that they determined NAb cutoff titer (titerS80) as suitable for comparing immunoassays and the other study estimated the 50% protective neutralization level as 54 IU/ml (95% CI 30e96 IU/ml), we set the cutoff titer as titerS80 and S 45.97 IU/m for the virus-live neutralizing assay.35,36 To assure our lab results performance, a subset of samples was tested by using other platforms of GenScript cPass sVNT, indicating that two platforms robustly correlated with specific titers of neutralizing antibodies for samples from acute phase. ..



    Similar Products

    cpass svnt “wild type” kit  (GenScript corporation)
    90
    GenScript corporation cpass svnt “wild type” kit
    Cpass Svnt “Wild Type” Kit, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cpass+svnt/cpass+svnt+kit/pm40288233-74-9-9
    Average 90 stars, based on 1 article reviews
    cpass svnt “wild type” kit - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    cpass surrogate virus neutralization test (svnt)  (GenScript corporation)
    90
    GenScript corporation cpass surrogate virus neutralization test (svnt)
    Cpass Surrogate Virus Neutralization Test (Svnt), supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cpass+svnt/cpass+surrogate+virus+neutralization+test/pm40288233-38-38-44
    Average 90 stars, based on 1 article reviews
    cpass surrogate virus neutralization test (svnt) - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    cpass svnt kit  (GenScript corporation)
    90
    GenScript corporation cpass svnt kit
    Cpass Svnt Kit, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cpass+svnt/cpass+svnt+kit/pmc11948354-146-58-63
    Average 90 stars, based on 1 article reviews
    cpass svnt kit - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    cpass svnt  (GenScript corporation)
    90
    GenScript corporation cpass svnt
    Illustration of the assay principle of (a) GenScript’s <t>cPass</t> <t>sVNT</t> kit and (b) Ahn et al.’s biotin-based sVNT. Reprinted with permission from ref . Copyright 2023 Elsevier.
    Cpass Svnt, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cpass+svnt/cpass+svnt/pmc11923957-200-21-24
    Average 90 stars, based on 1 article reviews
    cpass svnt - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    cpass tm svnt l00847-a  (GenScript corporation)
    90
    GenScript corporation cpass tm svnt l00847-a
    Illustration of the assay principle of (a) GenScript’s <t>cPass</t> <t>sVNT</t> kit and (b) Ahn et al.’s biotin-based sVNT. Reprinted with permission from ref . Copyright 2023 Elsevier.
    Cpass Tm Svnt L00847 A, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cpass+svnt/surrogate+virus+neutralization+test/pm40036878-113-7-11
    Average 90 stars, based on 1 article reviews
    cpass tm svnt l00847-a - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    cpass tm svnt  (GenScript corporation)
    90
    GenScript corporation cpass tm svnt
    Illustration of the assay principle of (a) GenScript’s <t>cPass</t> <t>sVNT</t> kit and (b) Ahn et al.’s biotin-based sVNT. Reprinted with permission from ref . Copyright 2023 Elsevier.
    Cpass Tm Svnt, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cpass+svnt/cpass+surrogate+virus+neutralization+test/pmc11879131-105-7-11
    Average 90 stars, based on 1 article reviews
    cpass tm svnt - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    surrogate virus neutralization (svnt) assay cpass  (GenScript corporation)
    90
    GenScript corporation surrogate virus neutralization (svnt) assay cpass
    Illustration of the assay principle of (a) GenScript’s <t>cPass</t> <t>sVNT</t> kit and (b) Ahn et al.’s biotin-based sVNT. Reprinted with permission from ref . Copyright 2023 Elsevier.
    Surrogate Virus Neutralization (Svnt) Assay Cpass, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cpass+svnt/surrogate+virus+neutralization+test++svnt+/pm39963186-63-27-33
    Average 90 stars, based on 1 article reviews
    surrogate virus neutralization (svnt) assay cpass - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    sars-cov-2 cpass surrogate virus neutralization test (svnt) kit  (GenScript corporation)
    90
    GenScript corporation sars-cov-2 cpass surrogate virus neutralization test (svnt) kit
    Antibody titers from the first and second blood samples by the participants’ demographics.
    Sars Cov 2 Cpass Surrogate Virus Neutralization Test (Svnt) Kit, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cpass+svnt/cpass+sars+cov+2+neutralization+antibody+detection+kit/pmc11862019-86-6-14
    Average 90 stars, based on 1 article reviews
    sars-cov-2 cpass surrogate virus neutralization test (svnt) kit - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Illustration of the assay principle of (a) GenScript’s cPass sVNT kit and (b) Ahn et al.’s biotin-based sVNT. Reprinted with permission from ref . Copyright 2023 Elsevier.

    Journal: Analytical Chemistry

    Article Title: Advances in Surrogate Neutralization Tests for High-Throughput Screening and the Point-of-Care

    doi: 10.1021/acs.analchem.5c00666

    Figure Lengend Snippet: Illustration of the assay principle of (a) GenScript’s cPass sVNT kit and (b) Ahn et al.’s biotin-based sVNT. Reprinted with permission from ref . Copyright 2023 Elsevier.

    Article Snippet: Ahn et al. immobilized ACE2 via His 6 -tag for improved binding of RBD ( Figure b) compared to the commercial cPass sVNT from GenScript ( Figure a).

    Techniques:

    Illustration of (a) the homogeneous sVNT using Tripart NanoLuc peptide fragments and (b) the molecular model of the predicted refolding of NanoLuc (PDB 5IBO ) (green) after complementation of fragments β10 and β9 driven by the interaction between SARS-CoV-2 spike trimer (purple) and ACE2 (fawn) (PDB 7A97 ). Reprinted with permission from ref . Copyright 2022 Macmillan Publishers Ltd. The article is licensed under a Creative Commons Attribution 4.0 International License http://creativecommons.org/licenses/by/4.0/ .

    Journal: Analytical Chemistry

    Article Title: Advances in Surrogate Neutralization Tests for High-Throughput Screening and the Point-of-Care

    doi: 10.1021/acs.analchem.5c00666

    Figure Lengend Snippet: Illustration of (a) the homogeneous sVNT using Tripart NanoLuc peptide fragments and (b) the molecular model of the predicted refolding of NanoLuc (PDB 5IBO ) (green) after complementation of fragments β10 and β9 driven by the interaction between SARS-CoV-2 spike trimer (purple) and ACE2 (fawn) (PDB 7A97 ). Reprinted with permission from ref . Copyright 2022 Macmillan Publishers Ltd. The article is licensed under a Creative Commons Attribution 4.0 International License http://creativecommons.org/licenses/by/4.0/ .

    Article Snippet: Ahn et al. immobilized ACE2 via His 6 -tag for improved binding of RBD ( Figure b) compared to the commercial cPass sVNT from GenScript ( Figure a).

    Techniques:

    Antibody titers from the first and second blood samples by the participants’ demographics.

    Journal: Vaccines

    Article Title: The Humoral Immune Response Against COVID-19 Through Vaccination in Hemodialysis Patients

    doi: 10.3390/vaccines13020170

    Figure Lengend Snippet: Antibody titers from the first and second blood samples by the participants’ demographics.

    Article Snippet: NAb was measured using the GenScript SARS-CoV-2 cPASS surrogate virus neutralization test (sVNT) kit (Genscript Biotech Corporation, Piscataway, NJ, USA) and spike-specific immunoglobulin G (IgG) was measured with the Euroimmun anti-SARS-CoV-2 IgG enzyme-linked immunosorbent assay (ELISA) (Euroimmun, Lübeck, Germany).

    Techniques: Infection, Sampling

    Locally estimated scatterplot smoothing curve based on data from the first blood sample collection, illustrating the relationship of antibody levels as follows: ( A – C ) inhibition rates (%) for the surrogate virus neutralization test (sVNT) against the wild-type (WT) strain, ( D – F ) inhibition rates (%) against the Omicron variant, and ( G – I ) IgG levels. The curves are plotted against the number of days since COVID-19 infection ( A , D , G ), the last vaccination ( B , E , H ), and the last exposure to COVID-19 ( C , F , I ). The blue line represents the regression line, and the shaded gray area indicates the 95% confidence interval.

    Journal: Vaccines

    Article Title: The Humoral Immune Response Against COVID-19 Through Vaccination in Hemodialysis Patients

    doi: 10.3390/vaccines13020170

    Figure Lengend Snippet: Locally estimated scatterplot smoothing curve based on data from the first blood sample collection, illustrating the relationship of antibody levels as follows: ( A – C ) inhibition rates (%) for the surrogate virus neutralization test (sVNT) against the wild-type (WT) strain, ( D – F ) inhibition rates (%) against the Omicron variant, and ( G – I ) IgG levels. The curves are plotted against the number of days since COVID-19 infection ( A , D , G ), the last vaccination ( B , E , H ), and the last exposure to COVID-19 ( C , F , I ). The blue line represents the regression line, and the shaded gray area indicates the 95% confidence interval.

    Article Snippet: NAb was measured using the GenScript SARS-CoV-2 cPASS surrogate virus neutralization test (sVNT) kit (Genscript Biotech Corporation, Piscataway, NJ, USA) and spike-specific immunoglobulin G (IgG) was measured with the Euroimmun anti-SARS-CoV-2 IgG enzyme-linked immunosorbent assay (ELISA) (Euroimmun, Lübeck, Germany).

    Techniques: Inhibition, Virus, Neutralization, Variant Assay, Infection

    Locally estimated scatterplot smoothing curve based on data from the second blood sample collection, illustrating the relationship of antibody levels as follows: ( A – C ) inhibition rates (%) for the surrogate virus neutralization test (sVNT) against the wild-type (WT) strain, ( D – F ) inhibition rates (%) against the Omicron variant, and ( G – I ) IgG levels. The curves are plotted against the number of days since COVID-19 infection ( A , D , G ), the last vaccination ( B , E , H ), and the last exposure to COVID-19 ( C , F , I ). The blue line represents the regression line, and the shaded gray area indicates the 95% confidence interval.

    Journal: Vaccines

    Article Title: The Humoral Immune Response Against COVID-19 Through Vaccination in Hemodialysis Patients

    doi: 10.3390/vaccines13020170

    Figure Lengend Snippet: Locally estimated scatterplot smoothing curve based on data from the second blood sample collection, illustrating the relationship of antibody levels as follows: ( A – C ) inhibition rates (%) for the surrogate virus neutralization test (sVNT) against the wild-type (WT) strain, ( D – F ) inhibition rates (%) against the Omicron variant, and ( G – I ) IgG levels. The curves are plotted against the number of days since COVID-19 infection ( A , D , G ), the last vaccination ( B , E , H ), and the last exposure to COVID-19 ( C , F , I ). The blue line represents the regression line, and the shaded gray area indicates the 95% confidence interval.

    Article Snippet: NAb was measured using the GenScript SARS-CoV-2 cPASS surrogate virus neutralization test (sVNT) kit (Genscript Biotech Corporation, Piscataway, NJ, USA) and spike-specific immunoglobulin G (IgG) was measured with the Euroimmun anti-SARS-CoV-2 IgG enzyme-linked immunosorbent assay (ELISA) (Euroimmun, Lübeck, Germany).

    Techniques: Inhibition, Virus, Neutralization, Variant Assay, Infection